Obesity, Oral Contraception, and Ovarian Suppression
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study proposes a double blind randomized clinical trial to include normal weight and
obese women who have normal ovulatory function at baseline; the investigators will randomize
women to 2 widely used OCs and evaluate ovarian follicle development and circulating
progesterone to assess ovarian suppression during OC use.
Phase:
Phase 4
Details
Lead Sponsor:
Columbia University
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)